Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThis updates the displayed ClinicalTrials.gov page revision/version from v3.5.2 to v3.5.3, indicating a site version refresh rather than any change to the underlying study details.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check55 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 is now displayed and the prior revision (v3.4.1) was removed. This change does not affect study details, eligibility criteria, or outcomes on the page.SummaryDifference0.4%

- Check98 days agoChange DetectedA site-wide notice about a lapse in government funding is now displayed, and the page revision has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.